The FH535 treatment partially reduced the transcript and protein CLIC4 levels in SSc fibroblasts, but had no effect on the basal CLIC4 expression in healthy fibroblasts (Figure 4A,C). This evidence concerns the gene CLIC4 and systemic sclerosis.